Corvus Pharmaceuticals Inc., of Burlingame, Calif., appointed Edith P. Mitchell to its board.
Opthea Ltd., of Melbourne, Australia, appointed Daniel Spiegelman to its board. He will also serve as chair of the company’s audit and risk committee.
Sangamo Therapeutics Inc., of Brisbane, Calif., appointed Kenneth Hillan to its board.
Savara Inc., of Austin, Texas, appointed Matthew Pauls chairman and interim CEO.
United Therapeutics Corp., of Silver Spring, Md., appointed Linda Maxwell to its board.